New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging

New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Newly Published Evidence Suggests that Concord Grape Juice May Improve Cognitive and Motor Skill Decline Associated with Aging Study of laboratory animals published in the March issue of the journal Nutrition suggests that Concord grape juice significantly improved the short-term memory and certain neuro-motor skills. Jellyfish Protein Shows Potential as an Anti-Aging Dietary Supplement Compan introduces Prevagen(TM), a dietary supplement consisting of the jellyfish protein aequorin, which has displayed anti-aging activity in laboratory studies. Jellyfish Protein Shows Potential as an Anti-Aging Dietary Supplement Compan introduces Prevagen(TM), a dietary supplement consisting of the jellyfish protein aequorin, which has displayed anti-aging activity in laboratory studies. Jellyfish Protein Shows Potential as an Anti-Aging Dietary Supplement Compan introduces Prevagen(TM), a dietary supplement consisting of the jellyfish protein aequorin, which has displayed anti-aging activity in laboratory studies. Jellyfish Protein Shows Potential as an Anti-Aging Dietary Supplement Compan introduces Prevagen(TM), a dietary supplement consisting of the jellyfish protein aequorin, which has displayed anti-aging activity in laboratory studies. Jellyfish Protein Shows Potential as an Anti-Aging Dietary Supplement Compan introduces Prevagen(TM), a dietary supplement consisting of the jellyfish protein aequorin, which has displayed anti-aging activity in laboratory studies. Jellyfish Protein Shows Potential as an Anti-Aging Dietary Supplement Compan introduces Prevagen(TM), a dietary supplement consisting of the jellyfish protein aequorin, which has displayed anti-aging activity in laboratory studies. Jellyfish Protein Shows Potential as an Anti-Aging Dietary Supplement Compan introduces Prevagen(TM), a dietary supplement consisting of the jellyfish protein aequorin, which has displayed anti-aging activity in laboratory studies. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Study at University of Texas Finds that Next Pharmaceutical’s Nexrutine® Inhibits Prostate Cancer Cell Proliferation Scientists led by principal investigator, Dr. Pratap Kumar, at the Department of Urology at the University of Texas Health Science Center, San Antonio, Texas have found that a proprietary extract from the bark of the Phellodendron tree prevents the growth of prostate cancer cells in laboratory studies. Study at University of Texas Finds that Next Pharmaceutical’s Nexrutine® Inhibits Prostate Cancer Cell Proliferation Scientists led by principal investigator, Dr. Pratap Kumar, at the Department of Urology at the University of Texas Health Science Center, San Antonio, Texas have found that a proprietary extract from the bark of the Phellodendron tree prevents the growth of prostate cancer cells in laboratory studies. Study at University of Texas Finds that Next Pharmaceutical’s Nexrutine® Inhibits Prostate Cancer Cell Proliferation Scientists led by principal investigator, Dr. Pratap Kumar, at the Department of Urology at the University of Texas Health Science Center, San Antonio, Texas have found that a proprietary extract from the bark of the Phellodendron tree prevents the growth of prostate cancer cells in laboratory studies. Study at University of Texas Finds that Next Pharmaceutical’s Nexrutine® Inhibits Prostate Cancer Cell Proliferation Scientists led by principal investigator, Dr. Pratap Kumar, at the Department of Urology at the University of Texas Health Science Center, San Antonio, Texas have found that a proprietary extract from the bark of the Phellodendron tree prevents the growth of prostate cancer cells in laboratory studies. Study at University of Texas Finds that Next Pharmaceutical’s Nexrutine® Inhibits Prostate Cancer Cell Proliferation Scientists led by principal investigator, Dr. Pratap Kumar, at the Department of Urology at the University of Texas Health Science Center, San Antonio, Texas have found that a proprietary extract from the bark of the Phellodendron tree prevents the growth of prostate cancer cells in laboratory studies. Study at University of Texas Finds that Next Pharmaceutical’s Nexrutine® Inhibits Prostate Cancer Cell Proliferation Scientists led by principal investigator, Dr. Pratap Kumar, at the Department of Urology at the University of Texas Health Science Center, San Antonio, Texas have found that a proprietary extract from the bark of the Phellodendron tree prevents the growth of prostate cancer cells in laboratory studies. UCLA study shows altering fatty acid levels in diet may reduce prostate cancer growth rate UCLA researchers, in an animal study published in the Aug. 1 issue of the journal Clinical Cancer Research, have found that altering the fatty acid ratio found in the typical Western diet to include more omega-3 fatty acids and decrease the amount of omega-6 fatty acids may reduce prostate cancer tumor growth rates and PSA levels. UCLA study shows altering fatty acid levels in diet may reduce prostate cancer growth rate UCLA researchers, in an animal study published in the Aug. 1 issue of the journal Clinical Cancer Research, have found that altering the fatty acid ratio found in the typical Western diet to include more omega-3 fatty acids and decrease the amount of omega-6 fatty acids may reduce prostate cancer tumor growth rates and PSA levels. UCLA study shows altering fatty acid levels in diet may reduce prostate cancer growth rate UCLA researchers, in an animal study published in the Aug. 1 issue of the journal Clinical Cancer Research, have found that altering the fatty acid ratio found in the typical Western diet to include more omega-3 fatty acids and decrease the amount of omega-6 fatty acids may reduce prostate cancer tumor growth rates and PSA levels. UCLA study shows altering fatty acid levels in diet may reduce prostate cancer growth rate UCLA researchers, in an animal study published in the Aug. 1 issue of the journal Clinical Cancer Research, have found that altering the fatty acid ratio found in the typical Western diet to include more omega-3 fatty acids and decrease the amount of omega-6 fatty acids may reduce prostate cancer tumor growth rates and PSA levels. Boron, Omega-3 Fatty Acids Promote Bone Strength Researchers from the USDA’s (United States Department of Agriculture) Grand Forks Human Nutrition Research Center fed rat pups either a low or boron-supplemented diet with palm (low omega-3) or canola (high omega-3) oil and then tested femur strength and tibial concentrations of certain minerals. Bone strength and flexibility were lowest in the boron-deprived rats fed canola oil, yet were greatest in boron-supplemented rats fed canola oil. Boron, Omega-3 Fatty Acids Promote Bone Strength Researchers from the USDA’s (United States Department of Agriculture) Grand Forks Human Nutrition Research Center fed rat pups either a low or boron-supplemented diet with palm (low omega-3) or canola (high omega-3) oil and then tested femur strength and tibial concentrations of certain minerals. Bone strength and flexibility were lowest in the boron-deprived rats fed canola oil, yet were greatest in boron-supplemented rats fed canola oil. Boron, Omega-3 Fatty Acids Promote Bone Strength Researchers from the USDA’s (United States Department of Agriculture) Grand Forks Human Nutrition Research Center fed rat pups either a low or boron-supplemented diet with palm (low omega-3) or canola (high omega-3) oil and then tested femur strength and tibial concentrations of certain minerals. Bone strength and flexibility were lowest in the boron-deprived rats fed canola oil, yet were greatest in boron-supplemented rats fed canola oil. Boron, Omega-3 Fatty Acids Promote Bone Strength Researchers from the USDA’s (United States Department of Agriculture) Grand Forks Human Nutrition Research Center fed rat pups either a low or boron-supplemented diet with palm (low omega-3) or canola (high omega-3) oil and then tested femur strength and tibial concentrations of certain minerals. Bone strength and flexibility were lowest in the boron-deprived rats fed canola oil, yet were greatest in boron-supplemented rats fed canola oil. Vitamin D, curcumin may help clear amyloid plaques found in Alzheimer's UCLA scientists and colleagues from UC Riverside and the Human BioMolecular Research Institute have found that a form of vitamin D, together with a chemical found in turmeric spice called curcumin, may help stimulate the immune system to clear the brain of amyloid beta, which forms the plaques considered the hallmark of Alzheimer's disease. Vitamin D, curcumin may help clear amyloid plaques found in Alzheimer's UCLA scientists and colleagues from UC Riverside and the Human BioMolecular Research Institute have found that a form of vitamin D, together with a chemical found in turmeric spice called curcumin, may help stimulate the immune system to clear the brain of amyloid beta, which forms the plaques considered the hallmark of Alzheimer's disease. Vitamin D, curcumin may help clear amyloid plaques found in Alzheimer's UCLA scientists and colleagues from UC Riverside and the Human BioMolecular Research Institute have found that a form of vitamin D, together with a chemical found in turmeric spice called curcumin, may help stimulate the immune system to clear the brain of amyloid beta, which forms the plaques considered the hallmark of Alzheimer's disease. Vitamin D, curcumin may help clear amyloid plaques found in Alzheimer's UCLA scientists and colleagues from UC Riverside and the Human BioMolecular Research Institute have found that a form of vitamin D, together with a chemical found in turmeric spice called curcumin, may help stimulate the immune system to clear the brain of amyloid beta, which forms the plaques considered the hallmark of Alzheimer's disease. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	Research Shows Tonalin® CLA Effective When Adults are Susceptible to Adding Weight and Fat La Grange, IL (Aug. 15, 2006) – A new study¹ published online today in the prestigious International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. Cognis' Tonalin® CLA (conjugated linoleic acid) is derived from natural safflower oil, is stimulant-free, and is the most clinically tested CLA on the market. “These findings suggest that CLA may serve a critical role in reducing a common weight and fat gain that occurs with age,” said Prof. Dale Schoeller, Ph.D., University of Wisconsin-Madison, and an author of the study. “About 65 percent of the U.S. population is obese or overweight—that’s a dangerous trend on many levels. We need more research like this to help overweight individuals when they are susceptible to weight gain.” Researchers at the University of Wisconsin-Madison recognized that “small, often cumulative weight gains during the holiday season contribute to ‘weight creep’ during adulthood.” They designed a study to determine if Tonalin® CLA supplementation would help overweight adults significantly reduce body fat over a six-month period and prevent weight gain during the holiday season. Their findings showed that participants taking Tonalin® CLA safely reduced their body fat mass by 2.2 pounds and their body weight by 1.3 pounds. In comparison, those in the placebo group gained 1.5 pounds of body fat mass and 2.4 pounds of body weight during the months that are especially problematic for overweight individuals. The study confirmed that taking CLA decreases body fat mass, maintains lean body mass, and aids weight management. Unlike many other studies on body composition, participants in this trial were not restricted by a controlled diet. Furthermore, CLA was well-tolerated among participants taking it for six months just as in earlier one- and two-year trials. Study subjects included 40 healthy, overweight men and women who took 4 grams of Tonalin® CLA or a placebo per day from August 2004 to March 2005. Participants followed “healthy lifestyle” advice and Dr. Schoeller explained that while adults in this trial were only moderately active, CLA supplementation can be most effective when taken as part of a daily regimen that includes exercise and a reasonable diet. Results of this double-blind, randomized, placebo-controlled study corroborate and expand upon earlier findings by Dr. Jean-Michael Gaullier. His studies revealed that CLA reduces body fat mass in overweight but otherwise healthy adults by as much as 9 percent. CLA helped participants in his studies keep off the lost fat during the two-year trial. In this most recent study report, Dr. Schoeller referred to that research and commented on inconsistent results found in other human CLA studies. He said most of the studies with conflicting findings have been 12 weeks or shorter and thus of “insufficient duration or have utilized body composition methods that are a little less accurate than the currently accepted criterion.” The UW study is the first to use the criterion of four-compartment body composition to more accurately reflect fat changes. Christine Peggau, Tonalin® CLA Senior Marketing Manager at Cognis, said “This science-based study offers a profound new way to begin tackling the obesity trend. If we can help overweight consumers when they need it most—during the food-filled holiday season and as they age—then this research suggests we will begin to see life-long benefits.” For more information about Tonalin® CLA or to place an order, visit www.cognis.com, call 800.673.3702, e-mail cognis.custserv@cognis-us.com, or fax 513.482.3576. About Tonalin® CLA: Tonalin® CLA is the original brand of CLA and is an exclusively licensed product of the Cognis Group. CLA is a polyunsaturated, conjugated fatty acid that is a natural part of the human diet, found primarily in meat and dairy products. Cognis produces Tonalin® CLA through a proprietary process that converts linoleic acid from safflowers into CLA, providing the highest quality of CLA available. Tonalin® CLA contains the lowest amount of non-naturally occurring isomers, a patent-protected attribute that provides food and dietary supplement manufacturers with the highest levels of ingredients known to be beneficial. Tonalin® CLA is available in several product forms—such as oil and water-dispersible powder—offering manufacturers a broad range of options for their products. About Cognis: Cognis (www.cognis.com) is a worldwide supplier of innovative specialty chemicals and nutritional ingredients. The company employs about 8,000 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural-source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, textiles, as well as agriculture and mining. The company holds a 50-percent stake in the joint venture Cognis Oleochemicals, one of the world’s leading manufacturers of oleochemicals. Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2005, Cognis recorded sales of 3.18 billion euros and an Adjusted EBITDA (earnings before interest, income taxes, depreciation, amortization and exceptional items) of 356 million euros. ### ¹ Watras AC, et al. Int. J. Obes. advance online publication, August 15, 2006 (doi:10.1038/sj.ijo.0803437) (www.nature.com/ijo/index.html)
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software